Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis

International Journal of Cancer

Volumn 140, Issue 11, 2017, Pages 2545-2556

  Cao, Hailong ^a,b   Xu, Mengque ^a,c   Dong, Wenxiao ^a   Deng, Baoru ^a   Wang, Sinan ^a   Zhang, Yujie ^a   Wang, Shan ^a   Luo, Shenhui ^a   Wang, Weiqiang ^a   Qi, Yanrong ^d   Gao, Jianxin ^d   Cao, Xiaocang ^a   Yan, Fang ^a,b   Wang, Bangmao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c ZHEJIANG UNIVERSITY   (China)

^d Tianjin Haibin People's Hospital   (China)

Author keywords

Apcmin + mice; deoxycholic acid; intestinal carcinogenesis; intestinal microbiota; tumor associated macrophages

Indexed keywords

APC PROTEIN; BETA CATENIN; BILE ACID; DEOXYCHOLIC ACID; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSBIOSIS; ENTERITIS; FECES MICROFLORA; INTESTINE CANCER; INTESTINE FLORA; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; ANIMAL; C57BL MOUSE; CARCINOGENESIS; CHEMICALLY INDUCED; DRUG EFFECTS; FECES; INFLAMMATION; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA; PATHOLOGY; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BILE ACIDS AND SALTS; CARCINOGENESIS; DEOXYCHOLIC ACID; DYSBIOSIS; FECES; INFLAMMATION; INTESTINES; MICE; MICE, INBRED C57BL; MICROBIOTA; WNT SIGNALING PATHWAY;

EID: 85014107164     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30643     Document Type: Article

References (53)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–E86.
2. Hold GL. Gastrointestinal microbiota and colon cancer. Dig Dis 2016;34:244–50.
3. Vipperla K, O'Keefe SJ. Diet, microbiota, and dysbiosis: a ‘recipe’ for colorectal cancer. Food Funct 2016;7:1731–40.
4. Bortlik M, Vitkova I, Papezova M, et al. Deficiency of adenomatous polyposis coli protein in sporadic colorectal adenomas and its associations with clinical phenotype and histology. World J Gastroenterol 2006;12:3901–5.
5. Savari S, Chandrashekar NK, Osman J, et al. Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model. Carcinogenesis 2016;37:491–9.
6. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014;12:661–72.
7. Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe 2014;15:317–28.
8. Abreu MT, Peek RM, Jr. Gastrointestinal malignancy and the microbiome. Gastroenterology 2014;146:1534–46, E1533.
9. Bernstein C, Holubec H, Bhattacharyya AK, et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 2011;85:863–71.
10. Saracut C, Molnar C, Russu C, et al. Secondary bile acids effects in colon pathology. Experimental mice study. Acta Cir Bras 2015;30:624–31.
11. Cook JW, Kennaway EL, Kennaway NM. Production of tumors in mice by deoxycholic acid. Nature 1940;145:627–9.
12. Ajouz H, Mukherji D, Shamseddine A. Secondary bile acids: an underrecognized cause of colon cancer. World J Surg Oncol 2014;12:164–8.
13. Kawano A, Ishikawa H, Kamano T, et al. Significance of fecal deoxycholic acid concentration for colorectal tumor enlargement. Asian Pac J Cancer Prev 2010;11:1541–6.
14. Bayerdörffer E, Mannes GA, Richter WO, et al. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology 1993;104:145–51.
15. Tsuei J, Chau T, Mills D, et al. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med (Maywood) 2014;239:1489–504.
16. Cao H, Luo S, Xu M, et al. The secondary bile acid, deoxycholate accelerates intestinal adenoma–adenocarcinoma sequence in Apc (min/+) mice through enhancing Wnt signaling. Fam Cancer 2014;13:563–71.
17. Joyce SA, Gahan CG. Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health. Annu Rev Food Sci Technol 2016;7:313–33.
18. Buffie CG, Bucci V, Stein RR, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015;517:205–8.
19. Islam KB, Fukiya S, Hagio M, et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011;141:1773–81.
20. Ridlon JM, Kang DJ, Ylemon PB, et al. Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014;30:332–8.
21. Seo SU, Kamada N, Muñoz-Planillo R, et al. Distinct commensals induce interleukin-1beta via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury. Immunity 2015;42:744–55.
22. Weingarden AR, Chen C, Bobr A, et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 2014;306:G310–G19.
23. Myers-Morales T, Bussell KM, D'Orazio SE. Fecal transplantation does not transfer either susceptibility or resistance to food borne listeriosis in C57BL/6 and BALB/c/By mice. F1000Res 2013;2:177.
24. Schuijt TJ, Lankelma JM, Scicluna BP, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2016;65:575–83.
25. Grill JI, Neumann J, Herbst A, et al. DRO1 inactivation drives colorectal carcinogenesis in ApcMin/+ mice. Mol Cancer Res 2014;12:1655–62.
26. Daniel H, Moghaddas Gholami A, Berry D, et al. High-fat diet alters gut microbiota physiology in mice. ISME J 2014;8:295–308.
27. Ijssennagger N, Belzer C, Hooiveld GJ, et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc Natl Acad Sci U S A 2015;112:10038–43.
28. Schloss PD, Gevers D, Westcott SL. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One 2011;6:e27310.
29. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009;75:7537–41.
30. Wang Q, Garrity Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007;73:5261–7.
31. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013;110:9066–71.
32. Kamada N, Nunez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014;146:1477–88.
33. Ni C, Wu P, Zhu X, et al. IFN-gamma selectively exerts pro-apoptotic effects on tumor-initiating label-retaining colon cancer cells. Cancer Lett 2013;336:174–84.
34. Deshmane SL, Kremlev S, Amini S, et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009;29:313–26.
35. Sica A, Schioppa T, Mantovani A, et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717–27.
36. Zhou W, Ke SQ, Huang Z, et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol 2015;17:170–82.
37. Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14:195–206.
38. Morgun A, Dzutsev A, Dong X, et al. Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks. Gut 2015;64:1732–43.
39. Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013;342:967–70.
40. Yamada Y, Mori H. Multistep carcinogenesis of the colon in Apc(Min/+) mouse. Cancer Sci 2007;98:6–10.
41. Prasad AR, Prasad S, Nguyen H, et al. Novel diet-related mouse model of colon cancer parallels human colon cancer. World J Gastrointest Oncol 2014;6:225–43.
42. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010;107:14691–6.
43. Martinez-Medina M, Denizot J, Dreux N, et al. Western diet induces dysbiosis with increased E. coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 2014;63:116–24.
44. Stacey M, Webb M. Studies on the antibacterial properties of the bile acids and some compounds derived from cholanic acid. Proc R Soc Lond B 1947;134:523–37.
45. Kurdi P, Kawanishi K, Mizutani K, et al. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol 2006;188:1979–86.
46. Floch MH, Binder HJ, Filburn B, et al. The effect of bile acids on intestinal microflora. Am J Clin Nutr 1972;25:1418–26.
47. Jean-Louis S, Akare S, Ali MA, et al. Deoxycholic acid induces intracellular signaling through membrane perturbations. J Biol Chem 2006;281:14948–60.
48. Margolles A, Yokota A. Bile acid stress in lactic acid bacteria and bifidobacteria. In: Sonomoto K, Yokota A, eds. Lactic acid bacteria and bifidobacteria: current progress in advanced research. Norfolk, VA: Caister Academic Press, 2011. 111–142.
49. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470–81.
50. Day SD, Enos RT, McClellan JL, et al. Linking inflammation to tumorigenesis in a mouse model of high-fat-diet-enhanced colon cancer. Cytokine 2013;64:454–62.
51. Wang L, Zhang Q. Application of the Apc(Min/+) mouse model for studying inflammation-associated intestinal tumor. Biomed Pharmacother 2015;71:216–21.
52. Mills CD, Lenz LL, Harris RA. A breakthrough: macrophage-directed cancer immunotherapy. Cancer Res 2016;76:513–6.
53. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997;275:1787–90.